Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FOUND: 22 - You Need To See This

If AstraZeneca goes to the US, it will be a major blow for London and Labour

Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy

The Guardian - UK

Fears over £160bn blow to London’s stock market as AstraZeneca considers listing move to US

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate

The Independent UK

Federal Watchdog Slams CBP for Mismanaging Millions in Tech Aimed To Detect Fentanyl at Border

A report found that of 361 systems installed since 2019, 166 (46%) were inoperable at some point, sometimes for as long as 344 days, resulting in more than 400,000 hours of downtime

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Risk to patient health from drug shortages is ‘distressing new normal’

Medicine shortages are causing unprecedented issues for patients, Community Pharmacy England said.

Evening Standard

Unilever To Acquire Men's Grooming Brand Dr. Squatch For $1.5 Billion Following Dollar Shave Club Setback

Unilever PLC (NYSE:UL) is acquiring personal care brand Dr. Squatch for $1.5 billion. This is the company’s next big bet on male grooming products after the deal with Dollar Shave Club fell flat in 2023, resulting in its sale to Nexus Capital Management.

Benzinga

What's Going On With Hims & Hers Health Stock Today?

Hims Hers Health Inc. (NYSE:HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here’s a look at what you need to know.

Benzinga

Cocaine and synthetic drugs power new era of global trafficking

The world drug market has never been so globalised, active and diverse, according to the United Nations – which marks International Day Against Drug Abuse and Illicit Trafficking on Thursday. RFI takes a look at the latest trends, from the explosion of cocaine to shifting routes and new synthetic drugs.

Radio France Internationale

Read news from The Economist, FT, and more,
with one subscription

Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga

Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Shares of Worthington Steel, Inc. (NYSE:WS) rose sharply in today's pre-market trading as the company reported stronger-than-expected financial results for the fourth quarter.

Benzinga

Purdue Pharma plan moves forward despite challenge from opioid victim

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

The Guardian - US

Louisiana files lawsuits alleging pharmaceutical giant CVS deceived customers in text messages

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies

The Independent UK

RFK Jr grilled on vaccine policies and healthcare fraud in bruising House hearing

US health secretary faced hours of questioning over budget cuts and accusations he lied to senators

The Guardian - US

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

Telehealth darling Hims Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable.

Benzinga

Why Did Novo Nordisk Pull the Plug on Hims Collaboration?

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, unapproved Wegovy knock-offs. Hims' stock tanked, and legal risks loom.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket

Shares of Nektar Therapeutics (NASDAQ:NKTR) rose sharply in today's pre-market trading after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin on June 24, 2025.

Benzinga

Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'

Hims Hers Health Inc. (NYSE:HIMS), CEO Andrew Dudum, has accused Novo Nordisk of exerting anticompetitive pressure to prioritize its weight-loss drug Wegovy over patient needs after the abrupt termination of its partnership with a pharmaceutical giant.

Benzinga

Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?

Shares of Ocugen Inc (NASDAQ:OCGN) are trading lower by more than 8% Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics in an all-stock deal.

Benzinga

CorMedix Stock Hits New 52-Week High On Updated Guidance: The Details

CorMedix Inc (NASDAQ:CRMD) shares are hitting new 52-week highs on Monday after the company raised its sales guidance for the second quarter.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

FDA to offer faster drug reviews to companies promoting 'national priorities'

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health

The Independent UK

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy

Al Jazeera

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

The Guardian - UK

PPE from company linked to Mone did not meet required safety standards, court told

Department of Health wants refund of £122m spent on unused surgical gowns, but PPE Medpro says it went into contract with ‘eyes wide open’

1 … 21 22 23 24

People

Alexandria OcasioCortez

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Department of Justice

Food and Drug Administration

338 stories

PPE Medpro

245 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.